In addition, a series of genes in the Ras pathway, including NF1, NRAS, KRANS, PTPN11, and CBL, are presented as a molecular diagnosis in 85% JMML patients (23–27). This evidence concerns the gene NF1 and juvenile myelomonocytic leukemia.